01.02.2016
This article was translated by an automatic translation system, and was therefore not reviewed by people.
transparent image
Prohibited use of Cephalexin lot Laboratorio Teuto
February 1, 2016
After a quality deviation, Anvisa determined the suspension of the distribution, sale and use of lot 3225197 of Cephalexin 500mg, tablet, generic drug Laboratorio Teuto Brasileiro S / A. The plot is valid until March 2016.
The drug showed unsatisfactory result for the appearance test as contained in the Fiscal Analysis Report of rebuttal No 105.CP / 2015 issued by the Foundation Ezequiel Dias (FUNED).
The product is an antibiotic indicated in the treatment of infections such as sinusitis.
With the Agency's decision, the company should promote stock gathering in the market.
.The Measure is in Resolution 265/2016 published Monday (01/02) in the Official Gazette (DOU).
Source: Anvisa
Our news are taken in full of our partner sites. For this reason, we can not change their content even in cases of typographical errors.
transparent image
This article was translated by an automatic translation system, and was therefore not reviewed by people.